WallStreetZenWallStreetZen

NASDAQ: SAVA
Cassava Sciences Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

SAVA earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$97.2M
Current Profit Margin
0%

SAVA Return on Equity

Current Company
-57.5%
Current Industry
-63.5%
Current Market
188%
SAVA's Return on Equity (-57.5%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when SAVA announces earnings.

SAVA Return on Assets

Current Company
-52.6%
Current Industry
2.9%
SAVA is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

SAVA Return on Capital Employed

Current Company
-70.72%
Current Industry
19.5%
SAVA's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

SAVA vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
SAVA$0.00-$95.69M-$97.22MN/AN/A
SLN$32.12M-$60.37M-$54.77M+216.26%N/A
VRDN$314.00k-$235.32M-$237.73M-48.16%N/A
ETNB$0.00-$133.26M-$142.19MN/AN/A
ARQT$59.61M-$227.43M-$262.14M+1,517.09%N/A
View Top Biotech Stocks

SAVA earnings dates

Next earnings date
Apr 29, 2024

Cassava Sciences Earnings & Revenue FAQ

What were SAVA's earnings last quarter?

On Invalid Date, Cassava Sciences (NASDAQ: SAVA) reported Q4 2023 earnings per share (EPS) of -$0.50, up 6.38% year over year. Total Cassava Sciences earnings for the quarter were -$20.92 million. In the same quarter last year, Cassava Sciences's earnings per share (EPS) was -$0.47.

If you're new to stock investing, here's how to buy Cassava Sciences stock.

What was SAVA's earnings growth in the past year?

As of Q2 2024, Cassava Sciences's earnings has grown year over year. Cassava Sciences's earnings in the past year totalled -$97.22 million.

What is SAVA's earnings date?

Cassava Sciences's earnings date is Invalid Date. Add SAVA to your watchlist to be reminded of SAVA's next earnings announcement.

What was SAVA's revenue last quarter?

On Invalid Date, Cassava Sciences (NASDAQ: SAVA) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Cassava Sciences's revenue was $0.00.

What was SAVA's revenue growth in the past year?

As of Q2 2024, Cassava Sciences's revenue has grown null year over year. Cassava Sciences's revenue in the past year totalled $0.00.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.